Table 1 Patients’characteristics

From: Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

 

All NSCLC

ADC/BAC

SCC

All

114

55a

59

Age (years): mean (s.d.)

61 (10)

61 (10)

61.5 (10)

Gender

 Men

91 (80%)

37 (68%)

54 (91.5%)

 Women

23 (20%)

18 (33%)

5 (8.5%)

Current/former smoker

106 (93%)

47 (87%)

59 (100%)

Never-smoker

7 (6%)

7 (13%)

0 (0%)

Stage pTNM

 I–IIIA

99 (87%)

45 (82%)

54 (91.5%)

 IIIB–IVb

15 (13%)

10 (18%)

5 (8.5%)

Histologic differentiation

 Well/moderate

74 (65%)

28 (57%)

46 (80%)

 Poor

32 (28%)

21 (43%)

11 (19%)

Tumour cell count

 <50%

52 (46%)

28 (51%)

24 (41%)

 ⩾50%

62 (54%)

27 (49%)

35 (59%)

Lung cancer relapse

 Yes

52 (45%)

28 (54%)

23 (39%)

 No

60 (53%)

24 (46%)

36 (61%)

Lung cancer death

 Yes

53 (46.5%)

28 (53%)

25 (42%)

 No

59 (52%)

25 (47%)

34 (58%)

  1. NSCLC=non-small cell lung cancer; ADC=adenocarcinoma; BAC=bronchioloalveolar carcinoma; SCC=squamous cell carcinoma.
  2. Clinical and pathological features of 114 NSCLC patients with NSCLC, classified by histological subtypes.
  3. aOf whom eight BAC features.
  4. b7 stages IV with unique metastasis.
Back to article page